Sort
51,593 grants matching “hepatitis”
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2004 · DK
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2003 · DK
Atlanta Center for the Childhood Liver Disease Research Network (ChiLDReN)
$900,000Saul Joseph Karpen · Emory University · U01 · FY2019 · DK
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
$900,000Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2020 · AI
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2001 · DK
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2005 · DK
Allergen Loaded Nanoparticles for Food Allergy Tolerance
$899,903Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation
$899,610Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI
Integrating HCV services into HIV programs for PWID in India
$899,435Shruti H Mehta · Johns Hopkins University · R01 · FY2019 · AI
Biofilm Epidemiology and Mechanisms in Colon Cancer
$899,343Cynthia L Sears · Johns Hopkins University · R01 · FY2016 · CA
iCyt Reflection Cell Sorter
$898,724Susan M Kaech · Yale University · S10 · FY2010 · RR
HCV Replication and Immunity
$898,548Christopher M. Walker · Research Inst Nationwide Children'S Hosp · U19 · FY2007 · AI
Retinoid Metabolism and Alcohol Induced Disease
$898,508William S Blaner · Columbia University Health Sciences · RC2 · FY2010 · AA
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Julie A Stoner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · HL
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Julie A Stoner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · HL
Individual, Network and Spatial Drivers of HIV and HCV among PWID in India
$897,280Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2016 · DA
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION
$897,263University Of Michigan At Ann Arbor · U01 · FY2003 · DK
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$897,025Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
$897,021T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C
$897,021T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$896,990Farhad Parhami · Max Biopharma, Inc. · R44 · FY2023 · DK
A preclinical multi-modal system for dynamic noninvasive assessment of liver disease
$896,265Tomasz Joseph Czernuszewicz · Sonovol, Inc. · R44 · FY2018 · DK
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
$896,178Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Novel therapeutics for fatty liver disease and type-II diabetes
$895,454Sarah A Compton · Southeast Techinventures, Inc. · R44 · FY2015 · DK
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS
$895,388Charles M. Stein · Vanderbilt University · P01 · FY2006 · GM